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Reported autochthonous dengue fever transmission in 
the United States has been limited to 5 south Texas bor-
der counties since 1980. We conducted a cross-sectional 
serosurvey in Brownsville, Texas, and Matamoros, Tamau-
lipas, Mexico (n = 600), in 2004 to assess dengue sero-
prevalence. Recent dengue infection was detected in 2% 
(95% conﬁ  dence interval [CI] 0.5%–3.5%) and 7.3% (95% 
CI 4.3%–10.3%) of residents in Brownsville and Matam-
oros, respectively. Past infection was detected in 40% (95% 
CI 34%–45%) of Brownsville residents and 78% (95% CI 
74%–83%) of Matamoros residents. For recent infection, 
only weekly family income <$100 was a signiﬁ  cant predic-
tor (adjusted odds ratio 3.2, 95% CI 1.3–8.0). Risk factors 
that predicted past dengue infection were presence of larval 
habitat, absence of air-conditioning and street drainage, and 
weekly family income <$100. Mosquito larvae were pres-
ent in 30% of households in both cities. Our results show 
that dengue fever is endemic in this area of the southern 
Texas–Mexico border.
D
engue fever is the most prevalent mosquitoborne viral 
disease in the world, causing an estimated 50 million 
infections and 25,000 deaths annually, with at least 2.5 bil-
lion persons at risk for transmission (1–4). Reports of au-
tochthonous dengue fever transmission on the US side of 
the Texas–Mexico border have been rare—only 64 cases 
were reported during 1980–1999, compared with 62,514 
cases on the Mexican side of the border (5–10). In the de-
bate over the potential for expansion of dengue and malaria 
with climate change, the border region has been cited as ev-
idence that mosquitoborne diseases are largely determined 
by public health capacity and socioeconomic factors, and 
speciﬁ  cally that US afﬂ  uence and lifestyle limit transmis-
sion of the disease (5,11–13). These conclusions, however, 
are largely based on incidence reports obtained from pas-
sive surveillance that contrast with the epidemiologic den-
gue situation on the ground.
Recent studies (14; J. Brunkard, unpub. data) suggest 
that dengue is substantially underreported on both sides of 
the border and prompted us to conduct an epidemiologic 
investigation in the neighboring cities of Brownsville, Tex-
as, USA, and Matamoros, Tamaulipas, Mexico. Our pri-
mary objectives were to assess population seroprevalence 
of dengue and to identify the most important risk factors 
for regional transmission. Public health agencies from both 
countries at the local, state, and national levels collaborated 
on the project. To our knowledge, this is the ﬁ  rst dengue 
seroprevalence study conducted in the lower Rio Grande 
Valley since 1980 (6).
Materials and Methods
Survey Design
In the fall of 2004, we conducted a binational, cross-
sectional serosurvey at the household level in Brownsville 
and Matamoros to measure dengue prevalence in the re-
gion. We interviewed members of 300 households in each 
Dengue Fever Seroprevalence 
and Risk Factors, Texas–Mexico 
Border, 2004
Joan Marie Brunkard,* Jose Luis Robles López,† Josue Ramirez,‡ Enrique Cifuentes,§ 
Stephen J. Rothenberg,§¶ Elizabeth A. Hunsperger,# Chester G. Moore,** Regina M. Brussolo,†† 
Norma A. Villarreal,†† and Brent M. Haddad*
*University of California, Santa Cruz, California, USA; †Servicios de 
Salud de la Jurisdicción Sanitaria III, Matamoros, Mexico; ‡Health 
Department–City of Brownsville, Brownsville, Texas, USA; §Insti-
tuto Nacional de Salud Pública, Cuernavaca, Mexico; ¶Centro de 
Investigacíon y de Estudios Avanzados–Instituto Politéchnico Na-
cional, Mérida, Mexico; #Centers for Disease Control and Preven-
tion, San Juan, Puerto Rico; **Colorado State University, Fort Col-
lins, Colorado, USA; and ††Laboratorio Estatal de Salud Pública 
de Tamaulipas, Ciudad Victoria, Mexico 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 10, October 2007  1477 GLOBAL POVERTY  RESEARCH
city for a total sample size of 600. Household selection 
was probability-based, using a stratiﬁ  ed, multistage, clus-
ter-sampling design. In the ﬁ  rst stage, 50 census tracts and 
50 basic geostatistical areas, the Mexican equivalent of the 
census tract, were selected by using probability-proportion-
al-to-size sampling with replacement. In the second stage, 
3 census blocks were randomly selected from each census 
tract, and for the ﬁ  nal stage, households were randomly or 
systematically selected.
The sampling frame was based on year 2000 census 
data for both the United States and Mexico (15,16). How-
ever, at the ﬁ  nal stage, we counted all houses in the block 
on-site and randomly selected starting points, allowing for 
the incorporation of population changes since the 2000 
censuses were conducted.
Household Serosurvey
We collected a blood sample (5 mL intravenously) from 
1 volunteer per household (>15 years of age), conducted 
larval inspections in and around the house, and interviewed 
participants by using a household survey that measured risk 
factors for dengue and public perception about the disease. 
Two survey teams consisting of 2 interviewers, a medical 
professional, and an entomologist worked concurrently in 
both cities to control for seasonal and temporal variance. 
The survey was timed to coincide with the height of the 
traditional dengue season (August–December), with most 
cases occurring in September and October. The survey ran 
for 5 weeks in October and November 2004. We recorded 
age, sex, and length of residence in the area for all par-
ticipants. We attempted to include only those residents who 
had lived in the region for >10 years, so that our serop-
revalence measure would more accurately reﬂ  ect regional 
transmission.
Before beginning the study, human subjects approval 
was obtained from the University of California Institutional 
Review Board. We pilot tested the survey questionnaire in 
neighborhoods in both cities in September 2004. Signed, 
informed consent was given by all survey participants in 
their preferred language (Spanish or English), including an 
additional consent form for the Health Insurance Portability 
and Accountability Act from US survey participants. Par-
ticipants <18 years of age (n = 6) were required to obtain a 
parent’s signed consent before giving their own. Participa-
tion in the survey was voluntary, and no gifts or ﬁ  nancial 
incentives were offered. Survey participants were notiﬁ  ed 
in person or by mail if they tested positive for recent den-
gue infection.
Laboratory Analysis
Serum samples were analyzed at the Laboratorio Es-
tatal de Salud Pública Tamaulipas (State Laboratory in 
Cd. Victoria, Tamaulipas, Mexico) by using DUO immu-
noglobulin (Ig) M/IgG capture ELISA (Panbio Inc., Bris-
bane, Queensland, Australia) to identify recent primary 
and secondary infections and an indirect IgG ELISA for 
past dengue infection (Panbio). The Dengue Branch (San 
Juan, Puerto Rico) of the Centers for Disease Control and 
Prevention (CDC) conducted conﬁ  rmatory testing on all 
samples that tested positive or equivocal for recent infec-
tion with capture IgM and IgG ELISAs (Panbio). CDC pro-
vided dengue-positive and -negative control serum speci-
mens to test on the ELISA kits (Panbio) before testing the 
serum samples. CDC also tested a random subsample (n = 
12) of serum samples that were negative for recent dengue 
infection.
Laboratory-based Classiﬁ  cation
Only samples conﬁ  rmed by CDC were classiﬁ  ed as 
recent infections. CDC criteria included samples with pres-
ence of IgM antibodies >0.2 optical density (OD) or pres-
ence of IgG antibodies with titers >40,960 (17). The IgG 
ELISA performed by CDC is based on titration of the sera 
to determine the antibody titer of IgG in the sera. Values 
of 40,960 are equivalent to the hemagglutination inhibition 
(HI) titer of 2,560, which the World Health Organization 
classiﬁ  es as recent secondary infections (18). Past infection 
was identiﬁ  ed by presence of low-titer dengue IgG antibod-
ies, as measured by indirect IgG ELISA (Panbio).
Plaque Reduction Neutralization Test (PRNT)
Additional conﬁ  rmatory tests were performed by CDC 
on 12 positive or equivocal samples by using a 90% re-
duction in numbers of plaques (PRNT90), as previously de-
scribed (19), to determine the speciﬁ  city of the antibody 
response to the infecting virus. Samples with a PRNT90- 
positive titer for a single serotype with an IgG titer >10,240 
were classiﬁ  ed as recent infections.
Entomologic Survey
We conducted larval sampling in and around the 
households to identify the mosquito species present and 
to determine whether the presence of Aedes aegypti, the 
primary dengue vector, was associated with recent or past 
dengue infection. We surveyed water-holding contain-
ers inside and outside the house and collected larvae and 
pupae. They were identiﬁ  ed by entomologists in both city 
health departments. The data were translated into house 
and Breteau indices, which are indicators of mosquito vec-
tor density (20).
Statistical Analysis
Adjusting the analysis to account for the survey design 
enables generalization across the statistical population. We 
used Stata version 9 (Stata Corp., College Station, TX, 
USA) for all survey design-adjusted descriptive and infer-
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ential analyses. We used binomial survey–adjusted Wald 
tests or Wilcoxon-Mann-Whitney rank sum tests to deter-
mine signiﬁ  cant differences in frequencies or distributions 
of key variables, respectively, between Matamoros and 
Brownsville. We conducted survey design–corrected, mul-
tivariate logistic regression based on a multivariate a priori 
hypothesis. We used the outcomes of recent and past den-
gue infection as dependent variables in separate models.
Independent variables in all models included Ae. ae-
gypti and Ae. albopictus mosquito habitat (number of wa-
ter-holding containers in and around the house), presence 
of air-conditioning and intact screens, household density, 
storage of water, street drainage, weekly family income, 
presence of immature Ae. aegypti on the premises, and his-
tory of crossing the border within the past 3 months. We 
constructed 3 models: separate models for recent and past 
dengue infection and a third model adding a dummy vari-
able for city, which allowed us to identify the independent 
variables in the model most responsible for the different 
prevalence in past dengue infection in the 2 cities. Twenty-
two exclusions were made because of missing data in the 
independent variables; all models contained 578 observa-
tions. We conducted Fisher exact tests to determine the ef-
fect of missing data on the dependent variables. All vari-
ables were entered into the model as a block without regard 
for signiﬁ  cance level.
Results
Serologic Testing
Serologic evidence of past dengue infection was iden-
tiﬁ  ed in 40% (95% conﬁ  dence interval [CI] 34%–45%) 
of Brownsville residents and 78% (95% CI 74%–83%) of 
Matamoros residents. An additional 3% of residents in both 
cities tested equivocal for prior dengue infection. Serop-
revalence of IgG dengue antibodies was remarkably con-
sistent with citywide averages across all age groups within 
both cities except for younger persons (ages 15–24 years) 
in Brownsville and older persons (ages >65 years) in Mat-
amoros. Seroprevalence was slightly higher in female par-
ticipants in both cities, but differences were not statistically 
signiﬁ  cant (Table 1).
Following a dengue infection, IgM responses are of 
limited duration, generally 1–2 months (21), and may not be 
elevated in secondary infections (22). Recent dengue infec-
tion—as indicated by presence of IgM antibodies >0.2 OD, 
IgG antibodies >40,960 (17), or PRNT90 results—was iden-
tiﬁ  ed in 2% (95% CI 0.5%–3.5%) of Brownsville residents 
and 7.3% (95% CI 4.3%–10.3%) of Matamoros residents. 
Most appeared to be secondary infections. Results from the 
PRNT90 assay (n = 3) indicated that dengue serotypes 1 and 
2 were circulating in the population (Table 2).
Comparison of Panbio Inc. and CDC Test Results
The IgG capture ELISA (Panbio) calculates a positive 
result based in units. This test determines the sample absor-
bance compared to a calibrant absorbance. Based on the kit, 
the interpretation of a positive result is >22 units and the in-
terpretation of this result is suggestive of a recent second-
ary dengue infection. The CDC IgG ELISA is based on the 
titration of the antibody present in the serum sample. This 
titration can be correlated with an HI value to determine a 
diagnosis of recent secondary dengue infection. When the 2 
tests are compared based on the deﬁ  nition of recent second-
ary dengue infection, the Panbio test is 87.5% sensitive and 
100% speciﬁ  c when using the CDC IgG ELISA as the ac-
cepted standard. All samples that tested positive for IgG an-
tibodies by Panbio test kits were conﬁ  rmed by CDC (3,17).
Demographics
Mean ages for Brownsville and Matamoros residents 
were 46.5 and 41.8 years, respectively (range 15–88 years). 
Most participants were female: 67% in Brownsville and 
75% in Matamoros. Based on interviewer observations, we 
believe that the dominant reason for unequal representation 
of men in the survey was their reluctance to give blood. 
There was little difference in mean length of residence in the 
2 cities (Brownsville, mean 25.6 years [range 3–77]; Mat-
amoros, mean 29.3 years [range 8–77]). A large percentage 
Table 1. Prevalence of IgG dengue antibodies by age and sex,  
Brownsville, Texas,  and Matamoros, Mexico, 2004* 
Characteristic  Brownsville, %  Matamoros, % 
Age group, y 
 15–24  8 79
 25–34  45 75
 35–44  43 72
 45–54  45 80
 55–64  35 79
 65–74  43 95
>75 38 90
Sex 
 Male  35 72
 Female  42 80
*IgG, immunoglobulin G. 
Table 2. Serologic test results for serosurvey, Brownsville, Texas, 
and Matamoros, Mexico, 2004* 
Serologic test  Brownsville, n  Matamoros, n 
Recent infection†  6 22
 IgM  >0.2  OD†  1 2
 IgG  >40,960  5 19
 PRNT90 1 (DEN-2)  2 (DEN-1) 
Past infection‡  119 235
*IgM, immunoglobulin M; OD, optical density; PRNT, plaque reduction 
neutralization test; DEN, dengue virus. 
†Laboratory-confirmed by the Dengue Branch, Centers for Disease 
Control and Prevention, defined by antidengue IgG titer >40,960 or IgM 
>0.2 OD. 
‡Laboratory-confirmed by using indirect IgG ELISA (Panbio Inc., Brisbane, 
Queensland, Australia). 
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of the survey participants had lived in their respective cit-
ies their entire lives: 25.3% in Brownsville and 41.7% in 
Matamoros; 83% of survey participants in Brownsville and 
99% in Matamoros had lived in their city >10 years.
Risk Factors
Many population characteristics were similar between 
the 2 cities: water and sewerage provision, household size, 
level of intact screens, and mosquito habitat and density. 
Key differences (p<0.01) included water storage practices, 
presence of air-conditioning, street drainage, income, pres-
ence of discarded tires, percentage of the population buying 
drinking water, and travel across the border (Table 3).
For recent infection, only weekly family income <$100 
was signiﬁ  cant as a predictor with an adjusted odds ratio 
(AOR) of 3.2 (95% CI 1.3–8.0), p = 0.01. All other vari-
ables were not signiﬁ  cant (Table 4). Design effects for all 
variables included in the model ranged from 0.74 to 1.06, 
indicating near identical variance to a design using simple 
random sampling.We ran the same model using past den-
gue infection as the dependent variable and found several 
epidemiologic risk factors associated with previous dengue 
infection: street drainage, air-conditioning, Ae. aegypti, 
and Ae. albopictus larval habitat in the neighborhood, and 
weekly family income <$100 US (Table 5).
Past dengue infection was signiﬁ  cantly different be-
tween the 2 cities (Pearson’s design-based F [1, 98] = 
78.01, p<0.0001). We added a city variable to the past 
infection model to determine its inﬂ  uence in explaining 
dengue prevalence in our model. In the model, city was 
highly signiﬁ  cant (AOR 4.36, t = 5.74, p<0.0005), and the 
model F improved from F (10, 89) = 5.42, p<0.0001 to F 
(11, 88) = 7.14, p<0.0001 with the addition of city to the 
model. Several variables that predicted past dengue infec-
tion changed signiﬁ  cantly with the addition of the city vari-
able to the model including stored water, street drainage, 
air-conditioning, and income, indicating that the inﬂ  uence 
of these factors on past infection differed by city. We tested 
for collinearity among all independent variables and found 
none; variance inﬂ  ation factors (VIF) for all tests were 
<1.82, mean VIF = 1.26, far lower than the accepted VIF 
>10 value for signiﬁ  cant collinearity (23).
Entomologic survey
We found mosquito larvae in 30% of households in 
both cities, but the relative abundance of the species dif-
fered between the 2 cities (Table 6). The house index for 
Ae. aegypti differed substantially between the 2 cities (14% 
and 25% in Brownsville and Matamoros, respectively). Ae. 
albopictus, an exotic species ﬁ  rst detected in Texas in the 
1980s, was more abundant in Brownsville (13%) than in 
Matamoros (4%), while Culex quinquefasciatus was pres-
ent at the same level in both cities. Breteau indices for all 
species were the same as house indices in both cities or 
differed by <1%.
Discussion
Brownsville and Matamoros are contiguous cities sep-
arated by the Rio Grande (Figure). Of the 6 persons with 
recent dengue infections in Brownsville, 4 had not crossed 
the border or traveled outside of the United States in the 
preceding 3 months and therefore acquired the infections 
locally (United States). Based on year 2000 census popu-
lation estimates of 161,546 and 376,279 for Brownsville 
and Matamoros, respectively, our point prevalence for den-
gue infections translates to 3,231 undocumented annual 
dengue infections in Brownsville (95% binomial Wald CI 
751–5,711) and 27,581 annual dengue infections in Mat-
amoros (95% binomial Wald CI 16,180–38,757). The den-
gue season came late in 2004, with several probable cases 
occurring in Matamoros in December and January after 
the conclusion of the survey, so our seroincidence rate was 
Table 3. Population characteristics and risk factors for dengue in Brownsville, Texas, and Matamoros, Mexico, 2004 
Risk factor  Brownsville, %  Matamoros, %  p value* 
Piped water  98 98 1.000
Buy water  95 99.7 <0.001
Sewerage 91 88 0.495
Street drainage  82 48 <0.001
Store water  4 34 <0.001
Screens present  76 64 0.009
Intact screens  40 32 0.054
Air-conditioning (room and central)  83 32 <0.001
Discarded tires  44 20 <0.001
Larval habitat  88 92 0.284
Mosquito larvae present  31 30 0.764
Crossed border (1 mo)  54 38 <0.001
Crossed border (3 mo)  66 45 <0.001
Median household weekly income ($ US)  300 100 <0.001
Mean persons/household  3.9 4.2 0.028
Mean hours/day at home  18.3 19.4 0.022
*Probability values of variables with percentages by adjusted Wald test; the remainder by 2-sample Wilcoxon-Mann-Whitney rank-sum test. 
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likely an underestimate of dengue transmission for that 
year (24).
Based on our seroprevalence results for past infection, 
dengue infections are clearly not being identiﬁ  ed by pas-
sive surveillance. This result was found in the outbreak of 
dengue in 1980 in which passive surveillance failed to de-
tect any dengue infections, while Hafkin et al. (6) found 63 
dengue infections through active surveillance.
Several factors may mask the region’s endemic dengue 
transmission. One possibility is that the dengue strains cir-
culating in the region result in mostly subclinical infections 
and mild diseases that do not require hospitalization and 
are managed through outpatient self-medication such as ac-
etaminophen. Another reason dengue is underreported on 
the US side of the border may be that a large percentage of 
these residents cross the border into Mexico for medical di-
agnoses and treatments. According to our surveys, 59% of 
Brownsville residents regularly cross the border for medical 
purposes; however, only 2% of Matamoros residents went 
to Brownsville for their medical needs. Lack of laboratory 
resources to conﬁ  rm dengue infection is another possible 
explanation. During our survey, physicians in Matamoros 
reported seeing a large number of patients with suspected 
dengue, but they were treated with acetaminophen and bed 
rest because resources were insufﬁ  cient to conduct labora-
tory conﬁ  rmation tests for dengue infection. The most com-
monly reported illness in the region is the ﬂ  u.
Risk Factors
Low income across both cities was the dominant risk 
factor for both recent and past dengue infection. Poverty 
is a proxy for many risk factors that make people vulner-
able to infectious diseases; some poverty-related factors 
were measured in this study while others were not. Our 
speciﬁ  c ﬁ  nding of the protective effect of air-conditioning 
has been found in another area of the US-Mexico border 
(14). Lack of street drainage appears to limit the ability of 
mosquito abatement and garbage collection trucks to enter 
these neighborhoods after a heavy rain. Also, the presence 
of water-holding containers facilitates vector proliferation 
in close contact to human hosts.
Epidemiologic Dynamics
Recent seroepidemiologic studies conducted in den-
gue-endemic countries have found high dengue seropreva-
lence: 29.5% in the Brazilian state of Goiás (25); 65.7% 
and 71%, respectively, among schoolchildren in Vietnam 
(26) and Thailand (27); 79.5% in Veracruz, Mexico (28); 
and 91% in Managua, Nicaragua (29). Historical accounts 
report widespread outbreaks affecting up to 500,000 people 
in the US Gulf Coast states during the Galveston, Texas, 
epidemic in 1922 (30) and outbreaks in 1934 and 1941 (31). 
However, very few population-based studies on dengue 
seroprevalence have been conducted in the United States. 
The most recent, conducted by Reiter et al. (14) in 1999, 
Table 4. Logistic regression results for recent dengue infection in Brownsville, Texas, and Matamoros, Mexico, 2004*
Variable Adjusted odds ratio  p value 95% Confidence interval  Deff
Income <$100 3.22 0.012 1.31–7.95 0.95
Missing income  1.35 0.671 0.34–5.42 1.00
Street drainage  0.69 0.395 0.29–1.65 1.00
Larval habitat  2.20 0.381 0.37–13.07 0.74
Air-conditioning 0.74 0.543 0.28–1.96 0.94
Intact screens  0.98 0.959 0.41–2.32 1.06
Store water  1.17 0.709 0.51–2.68 0.90
Aedes aegypti 1.05 0.912 0.47–2.31 0.92
Cross border, 3 mo  0.95 0.900 0.40–2.24 1.05
People/household 0.97 0.727 0.80–1.17 0.88
*Missing data in independent variables (n = 22) did not significantly change prevalence of recent or past dengue infection (p>0.10) in the remaining 578 
observations used in subsequent models. Deff, design effect, the ratio of variance between the survey design and simple random sampling.
Table 5. Logistic regression results for serologic evidence of past dengue infection in Brownsville, Texas, and Matamoros, Mexico,
2004*
Variable Adjusted odds ratio  p value 95% Confidence interval  Deff
Income <$100 2.59 0.000 1.58–4.26 0.92
Missing income  0.90 0.679 0.54–1.50 0.83
Street drainage  0.57 0.009 0.37–0.87 1.07
Larval habitat  2.35 0.008 1.26–4.41 1.00
Air-conditioning 0.58 0.014 0.38–0.89 1.04
Intact screens  1.35 0.111 0.93–1.95 0.90
Store water  1.62 0.079 0.95–2.76 1.19
Aedes aegypti 0.84 0.476 0.53–1.35 1.05
Cross border, 3 mo  0.90 0.581 0.62–1.31 0.93
People/household 1.06 0.300 0.95–1.19 1.31
*Missing data in independent variables (n = 22) did not significantly change prevalence of recent or past dengue infection (p>0.10) in the remaining 578 
observations used in subsequent models. Deff, design effect, the ratio of variance between the survey design and simple random sampling.
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found 23% seroprevalence in Laredo, Texas, and 48% se-
roprevalence in Nuevo Laredo, Tamaulipas, Mexico, ≈200 
miles (320 km) northwest of our study area. Our popula-
tion-based study reports the highest seroprevalence of den-
gue documented in the continental United States since at 
least 1950.
Demographic factors that could facilitate regional den-
gue transmission include immigration, which potentially 
introduces new strains of dengue from dengue-endemic re-
gions in Latin America, and a high local birth rate, which 
introduces a steady stream of newly susceptible persons. 
Cocirculation of multiple dengue serotypes has been previ-
ously documented in the region (10) and suggested from 
our results by the PRNT90, and cases of dengue hemor-
rhagic fever have increased in Mexico in the past 2 decades 
(24,32,33). This, coupled with the high background serop-
revalence identiﬁ  ed in this study, places the border popula-
tion at greater risk of future dengue hemorrhagic fever out-
breaks (34,35), although the role of sequential infections in 
disease severity is contested (36,37).
This study was motivated in part by the climate–den-
gue debate. While the role of climate change on future den-
gue transmission is unclear, we ﬁ  nd that dengue is already 
a problem in this area of the US–Mexico border. Because 
dengue infections are not being identiﬁ  ed through local 
surveillance efforts, we recommend proactive physician 
outreach emphasizing the potential for dengue infections 
and increased access to dengue diagnostic tests, especially 
on the Mexican side of the border, where a large propor-
tion of US and Mexican border residents seek their primary 
medical care. Improved systems of active binational sur-
veillance for dengue infections are needed, and sentinel 
sites should include the network of high-volume private 
clinicians practicing at the border. Ultimately, investments 
in local infrastructure, improvements in household screen-
ing, economic assistance for air-conditioning in dengue-en-
demic areas, and sustained community education about the 
importance of reducing larval habitat around the home will 
be necessary to reduce dengue transmission in this region.
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